Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| QUEST DIAGNOSTICS INCDGX · Entity 2118 | SVP for Diagnostic Services | July 22, 2026 | July 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
QUEST DIAGNOSTICS INC
Report date July 22, 2026 · Filed July 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,293 |
Reported balance
After 2026-07-22 transaction · row 1
1 source rowRow 1 · 2026-07-22 · Other · Acquired 46 · Balance 15,293 F1: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 22, 2026 Filed Jul 27, 2026 20:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 46 | $206.81 | $9,513.12 |
DisclosureSEC source: 0001022079-26-000083 · wk-form4_1785184455.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,293 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| April 20, 2026 Filed Apr 24, 2026 22:24 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 49 | $194.70 | $9,540.25 |
DisclosureSEC source: 0001022079-26-000049 · wk-form4_1777069472.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,247 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| March 05, 2026 Filed Mar 6, 2026 21:44 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 2,855 | $206.21 | $588,729.55 |
DisclosureSEC source: 0001022079-26-000027 · wk-form4_1772833437.xml · nonDerivative · entry 3 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,198 F3 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:44 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 2,827 | $204.86 | $579,139.22 |
DisclosureSEC source: 0001022079-26-000027 · wk-form4_1772833437.xml · nonDerivative · entry 2 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,053 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:44 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 5,682 | $204.86 | $1,164,014.52 |
DisclosureSEC source: 0001022079-26-000027 · wk-form4_1772833437.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,880 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 21:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 410 | $207.73 | $85,169.30 |
DisclosureSEC source: 0001022079-26-000020 · wk-form4_1772660286.xml · nonDerivative · entry 2 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,198 F2 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 230 | $204.86 | $47,117.80 |
DisclosureSEC source: 0001022079-26-000020 · wk-form4_1772660286.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,608 F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 22:13 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 958 | $204.83 | $196,227.14 |
DisclosureSEC source: 0001497368-26-000002 · wk-form4_1771625587.xml · nonDerivative · entry 4 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,838 F3 · shares: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:13 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 9,009 | $0.00 Strike: $204.96 | $0.00 |
DisclosureSEC source: 0001497368-26-000002 · wk-form4_1771625587.xml · derivative · entry 5 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,009 Underlying: Common Stock · 9,009 shares Expires 2036-02-18 F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:13 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 293 | $206.99 | $60,648.07 |
DisclosureSEC source: 0001497368-26-000002 · wk-form4_1771625587.xml · nonDerivative · entry 3 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,796 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:13 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 244 | $210.01 | $51,242.44 |
DisclosureSEC source: 0001497368-26-000002 · wk-form4_1771625587.xml · nonDerivative · entry 2 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,089 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:13 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001497368-26-000002 · wk-form4_1771625587.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,333 F1 · security: Represents an award of restricted stock units. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:33 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 5,662 | $121.81 Strike: $121.81 | $689,659.91 |
DisclosureSEC source: 0001022079-26-000008 · wk-form4_1770931987.xml · derivative · entry 4 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,662 shares Expires 2031-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F3 · derivative.exercise_date: The options vested in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:33 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 5,662 | $204.00 | $1,155,048.00 |
DisclosureSEC source: 0001022079-26-000008 · wk-form4_1770931987.xml · nonDerivative · entry 3 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,381 F2 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:33 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 5,662 | $121.81 | $689,659.91 |
DisclosureSEC source: 0001022079-26-000008 · wk-form4_1770931987.xml · nonDerivative · entry 2 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,043 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| January 28, 2026 Filed Feb 12, 2026 21:33 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 48 | $183.51 | $8,808.58 |
DisclosureSEC source: 0001022079-26-000008 · wk-form4_1770931987.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,381 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| October 21, 2025 Filed Oct 24, 2025 22:11 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 46 | $189.08 | $8,697.63 |
DisclosureSEC source: 0001022079-25-000230 · wk-form4_1761343884.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,333 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| August 21, 2025 Filed Aug 25, 2025 20:27 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 1,975 | $185.00 | $365,375.00 |
DisclosureSEC source: 0001022079-25-000200 · wk-form4_1756153676.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,269 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 20:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 4,532 | $112.17 Strike: $112.17 | $508,354.44 |
DisclosureSEC source: 0001022079-25-000198 · wk-form4_1755808441.xml · derivative · entry 3 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,532 shares Expires 2030-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F2 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 18, 2021, the second on February 18, 2022 and the final on February 18, 2023. Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 20:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 4,532 | $183.00 | $829,356.00 |
DisclosureSEC source: 0001022079-25-000198 · wk-form4_1755808441.xml · nonDerivative · entry 2 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,244 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 20:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 4,532 | $112.17 | $508,354.44 |
DisclosureSEC source: 0001022079-25-000198 · wk-form4_1755808441.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,776 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| August 15, 2025 Filed Aug 19, 2025 20:47 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 1,975 | $180.00 | $355,500.00 |
DisclosureSEC source: 0001497368-25-000007 · wk-form4_1755636429.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,244 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| August 06, 2025 Filed Aug 8, 2025 20:40 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 3,560 | $86.63 Strike: $86.63 | $308,402.80 |
DisclosureSEC source: 0001497368-25-000005 · wk-form4_1754685636.xml · derivative · entry 4 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,560 shares Expires 2029-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F3 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 18, 2020, the second on February 18, 2021 and the final on February 18, 2022. Read SEC document |
| August 06, 2025 Filed Aug 8, 2025 20:40 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 1,975 | $175.00 | $345,625.00 |
DisclosureSEC source: 0001497368-25-000005 · wk-form4_1754685636.xml · nonDerivative · entry 3 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,219 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| August 06, 2025 Filed Aug 8, 2025 20:40 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 3,560 | $175.00 | $623,000.00 |
DisclosureSEC source: 0001497368-25-000005 · wk-form4_1754685636.xml · nonDerivative · entry 2 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,185 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| August 06, 2025 Filed Aug 8, 2025 20:40 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 3,560 | $86.63 | $308,402.80 |
DisclosureSEC source: 0001497368-25-000005 · wk-form4_1754685636.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,745 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| July 21, 2025 Filed Jul 25, 2025 20:28 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 80 | $167.49 | $13,399.52 |
DisclosureSEC source: 0001022079-25-000188 · wk-form4_1753475302.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,185 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| April 21, 2025 Filed May 2, 2025 20:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 81 | $164.42 | $13,318.26 |
DisclosureSEC source: 0001022079-25-000128 · wk-form4_1746217917.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,087 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| March 26, 2025 Filed Mar 28, 2025 20:47 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 162 | $166.71 | $27,007.02 |
DisclosureSEC source: 0001022079-25-000101 · wk-form4_1743194819.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,988 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 21:36 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 2,280 | $173.74 | $396,127.20 |
DisclosureSEC source: 0001022079-25-000088 · wk-form4_1741210561.xml · nonDerivative · entry 3 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,150 F3 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award. F4 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 21:36 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 5,674 | $173.74 | $985,800.76 |
DisclosureSEC source: 0001022079-25-000088 · wk-form4_1741210561.xml · nonDerivative · entry 2 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,430 F2 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:36 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 106 | $173.74 | $18,416.44 |
DisclosureSEC source: 0001022079-25-000088 · wk-form4_1741210561.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,756 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 229 | $171.75 | $39,330.75 |
DisclosureSEC source: 0001022079-25-000073 · wk-form4_1740778616.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,853 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 21:43 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 320 | $169.71 | $54,307.20 |
DisclosureSEC source: 0001022079-25-000056 · wk-form4_1740174188.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,082 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:28 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 7,833 | $0.00 Strike: $165.30 | $0.00 |
DisclosureSEC source: 0001022079-25-000035 · wk-form4_1739572111.xml · derivative · entry 2 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,833 Underlying: Common Stock · 7,833 shares Expires 2035-02-12 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:28 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 2,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-25-000035 · wk-form4_1739572111.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,402 F1 · security: Represents an award of restricted stock units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 21:30 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 57 | $158.04 | $9,008.05 |
DisclosureSEC source: 0001022079-25-000016 · wk-form4_1738359001.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,345 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| October 21, 2024 Filed Oct 25, 2024 20:25 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 60 | $149.37 | $8,962.20 |
DisclosureSEC source: 0001022079-24-000196 · wk-form4_1729887909.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,258 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| July 22, 2024 Filed Jul 26, 2024 22:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 60 | $146.97 | $8,818.44 |
DisclosureSEC source: 0001022079-24-000165 · wk-form4_1722033092.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,162 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| April 22, 2024 Filed Apr 26, 2024 21:44 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 69 | $126.25 | $8,710.91 |
DisclosureSEC source: 0001022079-24-000105 · wk-form4_1714167846.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,062 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 26, 2024 Filed Mar 28, 2024 20:52 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 114 | $128.11 | $14,604.54 |
DisclosureSEC source: 0001022079-24-000088 · wk-form4_1711659111.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,981 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:55 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 105 | $126.36 | $13,267.80 |
DisclosureSEC source: 0001022079-24-000085 · wk-form4_1709330104.xml · nonDerivative · entry 2 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,082 F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:55 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 228 | $126.36 | $28,810.08 |
DisclosureSEC source: 0001022079-24-000085 · wk-form4_1709330104.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,187 F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:33 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 869 | $125.02 | $108,642.38 |
DisclosureSEC source: 0001022079-24-000065 · wk-form4_1709069626.xml · nonDerivative · entry 2 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,415 F2 · kind: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:33 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 2,388 | $125.02 | $298,547.76 |
DisclosureSEC source: 0001022079-24-000065 · wk-form4_1709069626.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,284 F1 · kind: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2021, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 139 | $125.02 | $17,377.78 |
DisclosureSEC source: 0001022079-24-000055 · wk-form4_1708724209.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,896 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 01:04 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 10,190 | $0.00 Strike: $127.81 | $0.00 |
DisclosureSEC source: 0001022079-24-000034 · wk-form4_1708131884.xml · derivative · entry 2 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,190 Underlying: Common Stock · 10,190 shares Expires 2034-02-14 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 01:04 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 2,446 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-24-000034 · wk-form4_1708131884.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,035 F1 · security: Represents an award of restricted share units. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 50 | $129.33 | $6,466.30 |
DisclosureSEC source: 0001022079-24-000011 · wk-form4_1706909646.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,589 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| October 23, 2023 Filed Oct 26, 2023 22:16 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 52 | $122.84 | $6,387.47 |
DisclosureSEC source: 0001022079-23-000163 · wk-form4_1698358589.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,492 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.